Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD20 Positive Non Hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02315118
What this trial is testing

Pilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell Malignancies

Who this might be right for
B-Cell Chronic Lymphocytic LeukemiaNon-Hodgkin's Lymphoma
National University Hospital, Singapore 18
Early research (Phase 1)Ended earlyNCT00036855
What this trial is testing

Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma

Who this might be right for
AIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaPost-transplant Lymphoproliferative Disorder+4 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT01007292
What this trial is testing

YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment

Who this might be right for
Non-Hodgkin's Lymphoma
Astellas Pharma Inc 43
Testing effectiveness (Phase 2)Study completedNCT01363128
What this trial is testing

Combination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Who this might be right for
Acute Lymphoblastic LeukemiaAdult Acute Lymphoblastic Leukemia in Complete RemissionBurkitt Leukemia+4 more
M.D. Anderson Cancer Center 72
Testing effectiveness (Phase 2)Ended earlyNCT03578198
What this trial is testing

Rituximab Plus MG4101 Indolent CD20-positive Non-Hodgkin Lymphoma (NHL)

Who this might be right for
CD20-positive Non-Hodgkin Lymphoma
Seoul National University Hospital 12
Early research (Phase 1)Study completedNCT02219737
What this trial is testing

Ibrutinib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
CD20 PositiveRecurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI) 26
Large-scale testing (Phase 3)UnknownNCT01933711
What this trial is testing

Rituximab Maintenance Therapy in Aggressive CD20 (Cluster of Differentiation Antigen 20) Positive Lymphoma and Mantle Cell Lymphoma

Who this might be right for
CD20+ Aggressive Lymphoma, Mantle Cell Lymphoma
University Hospital Heidelberg 328
Early research (Phase 1)Study completedNCT03218072
What this trial is testing

Evaluate Safety, Tolerability, PK and PD of HLX01 in Patients With CD20-positive B-cell Lymphomas

Who this might be right for
B-cell Lymphomas
Shanghai Henlius Biotech 12
Early research (Phase 1)Study completedNCT03057418
What this trial is testing

Open-label Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Auriхim

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, Follicular
Biointegrator LLC 7
Testing effectiveness (Phase 2)WithdrawnNCT01138579
What this trial is testing

Study of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell Transplantation

Who this might be right for
LeukemiaStem Cell Transplantation
Technical University of Munich
Early research (Phase 1)Ended earlyNCT00087009
What this trial is testing

Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder
Memorial Sloan Kettering Cancer Center 3
Large-scale testing (Phase 3)Study completedNCT01701232
What this trial is testing

Safety and Efficacy Study of BCD-020 in Therapy of Indolent Non-Hodgkin's Lymphoma

Who this might be right for
Follicular Non-Hodgkin's LymphomaNodal Marginal Zone LymphomaSplenic Marginal Zone Lymphoma
Biocad 174
Large-scale testing (Phase 3)Ended earlyNCT00169169
What this trial is testing

Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma

Who this might be right for
CD20-Positive Large B-Cell Lymphoma
Lymphoma Study Association 430
Testing effectiveness (Phase 2)Study completedNCT01682044
What this trial is testing

Pegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone Lymphoma

Who this might be right for
Contiguous Stage II Grade 1 Follicular LymphomaContiguous Stage II Grade 2 Follicular LymphomaContiguous Stage II Grade 3 Follicular Lymphoma+30 more
Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT00048737
What this trial is testing

Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies

Who this might be right for
LymphomaLeukemia
M.D. Anderson Cancer Center 70
Early research (Phase 1)Study completedNCT04152148
What this trial is testing

A Phase I Clinical Trial of BAT4306F on Safety, Tolerability and Pharmacokinetics for Patients

Who this might be right for
Non-Hodgkin's Lymphoma
Bio-Thera Solutions 16
Large-scale testing (Phase 3)Study completedNCT02213263
What this trial is testing

PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)

Who this might be right for
Follicular Lymphoma
Pfizer 394
Large-scale testing (Phase 3)UnknownNCT03777085
What this trial is testing

Study of TQB2303 in Patients With CD20-Positive Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 230
Testing effectiveness (Phase 2)Study completedNCT01788189
What this trial is testing

Lenalidomide, MTX, Ara-C and Rituximab in Relapsed Aggressive B-cell Lymphomas

Who this might be right for
B-cell Lymphoma
University Hospital, Essen 37
Testing effectiveness (Phase 2)Study completedNCT00080886
What this trial is testing

Rituximab, Carmustine; Cytarabine, Etoposide, & Melphalan; Stem Cell Transplantation for Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Nebraska 68
Next Page